371 related articles for article (PubMed ID: 20009004)
1. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Fajt M; Petrov A
Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel desensitization after drug-eluting stent placement.
von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel desensitization: case report and review of published protocols.
Owen P; Garner J; Hergott L; Page RL
Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
[TBL] [Abstract][Full Text] [Related]
4. Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
Walker NE; Fasano MB; Horwitz PA
J Invasive Cardiol; 2006 Jul; 18(7):341-4. PubMed ID: 16816444
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity.
Walker NE; Fasano MB; Hobbs RA; Horwitz PA
Crit Pathw Cardiol; 2007 Mar; 6(1):26-9. PubMed ID: 17667884
[TBL] [Abstract][Full Text] [Related]
6. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
Silberman S; Neukirch-Stoop C; Steg PG
Am J Cardiol; 2005 Feb; 95(4):509-10. PubMed ID: 15695141
[TBL] [Abstract][Full Text] [Related]
7. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel (Plavix) desensitization: a case series.
Camara MG; Almeda FQ
Catheter Cardiovasc Interv; 2005 Aug; 65(4):525-7. PubMed ID: 15973671
[TBL] [Abstract][Full Text] [Related]
9. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
11. Use of prasugrel in a patient with clopidogrel hypersensitivity.
Peppard SR; Held-Godgluck BM; Beddingfield R
Ann Pharmacother; 2011 Oct; 45(10):e54. PubMed ID: 21896923
[TBL] [Abstract][Full Text] [Related]
12. Management of clopidogrel hypersensitivity without drug interruption.
Campbell KL; Cohn JR; Fischman DL; Walinsky P; Mallya R; Jaffrani W; Savage MP
Am J Cardiol; 2011 Mar; 107(6):812-6. PubMed ID: 21247516
[TBL] [Abstract][Full Text] [Related]
13. Desensitization to clopidogrel: a tailor-made protocol.
Barreira P; Cadinha S; Malheiro D; Moreira da Silva JP
Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):53-5. PubMed ID: 24702878
[TBL] [Abstract][Full Text] [Related]
14. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
Shaker M; Lobb A; Jenkins P; O'Rourke D; Takemoto SK; Sheth S; Burroughs T; Dykewicz MS
J Allergy Clin Immunol; 2008 Jan; 121(1):81-7. PubMed ID: 17716716
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG
Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
[TBL] [Abstract][Full Text] [Related]
18. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting.
Shennib H; Endo M; Benhameid O
Heart Surg Forum; 2003; 6(5):288-91. PubMed ID: 14721795
[TBL] [Abstract][Full Text] [Related]
19. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy.
Page NA; Schroeder WS
Ann Pharmacother; 2007 Jan; 41(1):61-7. PubMed ID: 17200429
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
